What is it about?

Treating infections is moving towards therapy tailored to each patient, balancing effectiveness, side effects and the need to protect antibiotics from resistance. In this editorial for a Special Issue of the journal Antibiotics, which I edited, I summarize the main messages of the collected papers. They include evidence that shorter antibiotic courses work for common infections such as bloodstream infections, pneumonia and spinal infections, that switching from intravenous to oral therapy is possible in bone infections, shortening hospital stays, that the long-standing use of rifampicin in staphylococcal bone infections needs stronger evidence, that combination therapies, often including fosfomycin, are promising for difficult bacteria such as vancomycin-resistant enterococci and Pseudomonas, and that therapeutic drug monitoring is increasingly important to adjust doses and limit toxicity.

Featured Image

Why is it important?

Special clinical situations - bone infections, resistant bacteria, fragile patients - are where standard recommendations often fail. This editorial gives clinicians a concise overview of current evidence and open questions, encouraging a more personalized and stewardship-oriented use of antibiotics.

Perspectives

Serving as Guest Editor of this Special Issue was a great opportunity to bring together colleagues working on the real-life problems we face daily. Many of the themes - short courses, oral switch, fosfomycin combinations, drug monitoring - reflect the direction I believe infectious diseases practice should take.

Professor Stefano Di Bella
Universita degli Studi di Trieste

Read the Original

This page is a summary of: Antibiotics Usage in Special Clinical Situations, Antibiotics, December 2023, MDPI AG,
DOI: 10.3390/antibiotics13010034.
You can read the full text:

Read

Contributors

The following have contributed to this page